As the global economy mends, the 2021 growth of Histone Deacetylase 1 will have significant change from previous year. According to our (LP Information) latest study, the global Histone Deacetylase 1 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Histone Deacetylase 1 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Histone Deacetylase 1 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Histone Deacetylase 1 market, reaching US$ million by the year 2028. As for the Europe Histone Deacetylase 1 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Histone Deacetylase 1 players cover 4SC AG, Acetylon Pharmaceuticals, Inc., Chipscreen Biosciences Ltd, and Curis, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Histone Deacetylase 1 market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
RCY-1305
HG-3001
CS-3158
ACY-957
ST-3595
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Alopecia
Endometrial Cancer
Myelofibrosis
Neurology
Skin Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
4SC AG
Acetylon Pharmaceuticals, Inc.
Chipscreen Biosciences Ltd
Curis, Inc.
GlaxoSmithKline Plc
HitGen LTD
IRBM Science Park SpA
Italfarmaco S.p.A.
MEI Pharma, Inc.
Merck & Co., Inc.
Mirati Therapeutics Inc.
Oncolys BioPharma Inc.
Sigma-Tau S.p.A.
Syndax Pharmaceuticals, Inc.
TetraLogic Pharmaceuticals